|
DDHD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.975900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.647010E-01 |
| Normal-vs-Stage2 |
1.670020E-01 |
| Normal-vs-Stage3 |
8.221900E-04 |
| Normal-vs-Stage4 |
1.472850E-01 |
| Stage1-vs-Stage2 |
6.011600E-01 |
| Stage1-vs-Stage3 |
9.800200E-03 |
| Stage1-vs-Stage4 |
6.408200E-01 |
| Stage2-vs-Stage3 |
2.860800E-01 |
| Stage2-vs-Stage4 |
9.576200E-01 |
| Stage3-vs-Stage4 |
1.790810E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.291810E-01 |
| Normal-vs-AfricanAmerican |
6.810600E-01 |
| Normal-vs-Asian |
6.401700E-03 |
| Caucasian-vs-AfricanAmerican |
6.000200E-01 |
| Caucasian-vs-Asian |
8.422100E-02 |
| AfricanAmerican-vs-Asian |
2.390800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.573600E-02 |
| Normal-vs-Female |
7.010200E-02 |
| Male-vs-Female |
7.079200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.911020E-01 |
| Normal-vs-Age(41-60Yrs) |
2.240400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.762300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.432590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.040380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.385400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.019800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.467400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.103000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.113000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.54439999999956E-05 |
| Classical-VS-Follicular |
1.695990E-03 |
| Classical-VS-Other |
2.022000E-01 |
| Classical-VS-Normal |
4.104800E-01 |
| Tall-VS-Follicular |
2.805400E-01 |
| Tall-VS-Other |
7.894400E-01 |
| Tall-VS-Normal |
7.71070000000762E-05 |
| Follicular-VS-Other |
7.966400E-01 |
| Follicular-VS-Normal |
1.838970E-03 |
| Other-VS-Normal |
7.473800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.049600E-02 |
| Normal-vs-N1 |
1.894600E-01 |
| N0-vs-N1 |
5.079800E-01 |
|
|
